Nilou Arden

853 total citations · 1 hit paper
12 papers, 583 citations indexed

About

Nilou Arden is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Nilou Arden has authored 12 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Biomedical Engineering. Recurrent topics in Nilou Arden's work include Viral Infectious Diseases and Gene Expression in Insects (5 papers), CRISPR and Genetic Engineering (3 papers) and RNA Interference and Gene Delivery (3 papers). Nilou Arden is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (5 papers), CRISPR and Genetic Engineering (3 papers) and RNA Interference and Gene Delivery (3 papers). Nilou Arden collaborates with scholars based in United States. Nilou Arden's co-authors include Michael J. Betenbaugh, Adam C. Fisher, Lawrence X. Yu, Katherine M. Tyner, Sau L. Lee, Joel Welch, Michael J. Betenbaugh, Brian S. Majors, George A. Oyler and Sau Lee and has published in prestigious journals such as Trends in biotechnology, International Journal of Pharmaceutics and Biotechnology and Bioengineering.

In The Last Decade

Nilou Arden

12 papers receiving 555 citations

Hit Papers

Industry 4.0 for pharmaceutical manufacturing: Preparing ... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nilou Arden United States 9 310 94 91 54 49 12 583
Maria M. Papathanasiou United Kingdom 15 262 0.8× 106 1.1× 37 0.4× 32 0.6× 49 1.0× 42 691
John Washbrook United Kingdom 11 224 0.7× 49 0.5× 21 0.2× 41 0.8× 56 1.1× 21 414
Adam C. Fisher United States 19 858 2.8× 145 1.5× 227 2.5× 58 1.1× 283 5.8× 35 1.4k
Harini Narayanan Switzerland 15 486 1.6× 143 1.5× 16 0.2× 33 0.6× 98 2.0× 20 744
Takeshi Shikanai Japan 10 184 0.6× 43 0.5× 16 0.2× 42 0.8× 26 0.5× 25 412
Rafael S. Costa Portugal 14 453 1.5× 121 1.3× 53 0.6× 8 0.1× 21 0.4× 49 683
Michael Sokolov Switzerland 20 794 2.6× 225 2.4× 21 0.2× 53 1.0× 156 3.2× 27 1.1k
Youhua Zhang China 17 270 0.9× 146 1.6× 36 0.4× 9 0.2× 12 0.2× 53 799
Hongyu Zhou China 6 148 0.5× 113 1.2× 13 0.1× 12 0.2× 26 0.5× 18 505
Hiroshi Matsuno Japan 21 761 2.5× 82 0.9× 116 1.3× 6 0.1× 11 0.2× 98 1.3k

Countries citing papers authored by Nilou Arden

Since Specialization
Citations

This map shows the geographic impact of Nilou Arden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilou Arden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilou Arden more than expected).

Fields of papers citing papers by Nilou Arden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nilou Arden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilou Arden. The network helps show where Nilou Arden may publish in the future.

Co-authorship network of co-authors of Nilou Arden

This figure shows the co-authorship network connecting the top 25 collaborators of Nilou Arden. A scholar is included among the top collaborators of Nilou Arden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nilou Arden. Nilou Arden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Arden, Nilou, et al.. (2021). Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future. International Journal of Pharmaceutics. 602. 120554–120554. 218 indexed citations breakdown →
2.
Zhao, Jianan, et al.. (2021). Influences of puff protocols and upper airway anatomy on cannabis pharmacokinetics: A CFPD-PK study. Computers in Biology and Medicine. 132. 104333–104333. 9 indexed citations
3.
Fisher, Adam C., et al.. (2020). An Overview of Drug Substance Manufacturing Processes. AAPS PharmSciTech. 21(7). 271–271. 5 indexed citations
5.
Tian, Geng, et al.. (2019). Quality risk assessment and mitigation of pharmaceutical continuous manufacturing using flowsheet modeling approach. Computers & Chemical Engineering. 129. 106508–106508. 34 indexed citations
6.
Arden, Nilou, et al.. (2018). Considerations for risk and control of mycoplasma in bioprocessing. Current Opinion in Chemical Engineering. 22. 161–166. 6 indexed citations
7.
Majors, Brian S., Nilou Arden, George A. Oyler, et al.. (2008). E2F-1 overexpression increases viable cell density in batch cultures of Chinese hamster ovary cells. Journal of Biotechnology. 138(3-4). 103–106. 28 indexed citations
8.
Arden, Nilou, et al.. (2007). Chemical Caspase Inhibitors Enhance Cell Culture Viabilities and Protein Titer. Biotechnology Progress. 23(2). 506–511. 16 indexed citations
9.
Arden, Nilou & Michael J. Betenbaugh. (2006). Regulating apoptosis in mammalian cell cultures. Cytotechnology. 50(1-3). 77–92. 19 indexed citations
10.
Arden, Nilou, et al.. (2006). Inhibiting the apoptosis pathway using MDM2 in mammalian cell cultures. Biotechnology and Bioengineering. 97(3). 601–614. 25 indexed citations
11.
Arden, Nilou & Michael J. Betenbaugh. (2004). Life and death in mammalian cell culture: strategies for apoptosis inhibition. Trends in biotechnology. 22(4). 174–180. 181 indexed citations
12.
Betenbaugh, Michael J., et al.. (2004). Cell Engineering Blocks Cell Stress and Improves Biotherapeutic Production. BioProcessing Journal. 3(2). 23–28. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026